Connect with us

Legal & Regulation

CannTrust Chairman and CEO Reportedly Informed of Unlicensed Cannabis Growing in November

Published

on

CannTrust Chairman and CEO Reportedly Informed of Unlicensed Cannabis Growing in November

On July 8, 2019, CannTrust issued a press release on its receipt Health Canada’s compliance report informing the company of its Pelham, Ontario facility and the non-compliant cannabis growth occurring therein. According to the press release, the company “has accepted Health Canada’s non-compliance findings and has taken actions to ensure current and future compliance.”

It appears, based on a report by Globe and Mail, that CannaTrust’s chairman, chief executive officer, and other company executives were aware of the unlicensed rooms and cannabis cultivation, several months before the regulator’s discovery. Emails between chairman Eric Paul and CEO Peter Aceto were seen by the Globe and Mail. The emails indicate that the chairman and CEO were informed of the illegal cultivation. The emails reportedly show that Graham Lee communicated to Paul and Aceto that the company “dodged some bullets” after the Canadian government had conducted an inspection, but had not found the hidden growth.

Although Canada legalized adult-use of marijuana, marijuana remains illegal in the United States under federal law and is classified as a Schedule I substance.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.